High Times, Low Sats: Diffuse Pulmonary Infiltrates Associated with Chronic Synthetic Cannabinoid Use

被引：44

作者：

Alhadi S. ^{[1
]}

Tiwari A. ^{[1
]}

Vohra R. ^{[1
]}

Gerona R. ^{[2
]}

Acharya J. ^{[1
]}

Bilello K. ^{[1
]}

机构：

[1] UCSF-Fresno Medical Center, Fresno, CA

[2] UCSF School of Medicine, San Francisco General Hospital, San Francisco, CA

来源：

Journal of Medical Toxicology | 2013年 / 9卷 / 2期

关键词：

AM-2201; JWH-018; New drugs of abuse; Pulmonary toxicity; Synthetic cannabinoids;

D O I：

10.1007/s13181-013-0288-9

中图分类号：

学科分类号：

摘要：

Introduction: In recent years, cases of severe adverse effects from recreational use of synthetic cannabinoids (SC) have established that these agents represent a novel toxicologic hazard. Case Report: A 21-year-old male presenting as a vehicular trauma victim was noted with diffuse pulmonary infiltrates related to chronic inhalation of multiple synthetic cannabinoid-containing products. Chest imaging revealed bilateral, subacute lung infiltrates; histopathological analysis of bronchial and alveolar tissues revealed an inflammatory process. An extensive workup failed to identify infectious, malignant, autoimmune, or hematologic causes of the syndrome, and toxicological analysis of the blood and body fluids confirmed the presence of multiple synthetic cannabinoids and metabolites. The patient recovered after an 8-day ICU course, wherein he received antibiotics, steroids, and mechanical ventilation. Discussion: This case contributes to the currently evolving knowledge about SC agents, adding a rarely described pulmonary complication to the growing list of adverse effects associated with these products. © 2013 American College of Medical Toxicology.

引用

页码：199 / 206

页数：7

共 27 条

[1] Wells, D.L., Ott, C.A., The "new" marijuana (2011) Ann Pharmacother, 45 (3), pp. 414-417
[2] Vearrier, D., Osterhoudt, K., A teenager with agitation: higher than she should have climbed (2010) Ped Emerg Care, 26 (6), pp. 462-465
[3] Seely, K.A., Lapoint, J., Moran, J.H., Fattore, L., Spice drugs are more than harmless herbal blends: a review of the pharmacology and toxicology of synthetic cannabinoids (2012) Prog Neuropsychopharmacol Biol Psychiatry, , 2012 Apr 26
[4] Logan, B.K., Reinhold, L.E., Xu, A., Diamond, F.X., Identification of synthetic cannabinoids in herbal incense blends in the United States (2012) J Forensic Sci, , 2012 Jul 26
[5] Tofighi, B., Lee, J.D., Internet highs-seizures after consumption of synthetic cannabinoids purchased online (2012) J Addict Med, 6 (3), pp. 240-241
[6] Forrester, M., Kleinschmidt, K., Schwarz, E., Young, A., Synthetic cannabinoid and marijuana exposures reported to poison centers (2012) Hum Exp Toxicol, , 2012 Aug 2
[7] Cohen, J., Morrison, S., Greenberg, J., Saidinejad, M., Clinical presentation of intoxication due to synthetic cannabinoids (2012) Pediatrics, 129 (4), pp. e1064-e1067
[8] Ashton, J.C., Synthetic cannabinoids as drugs of abuse (2012) Curr Drug Abuse Rev, 5 (2), pp. 158-168
[9] Castellanos, D., Thornton, G., Synthetic cannabinoid use: recognition and management (2012) J Psychiatr Pract, 18 (2), pp. 86-93
[10] Rosenbaum, C.D., Carreiro, S.P., Babu, K.M., Here today, gone tomorrow...and back again? A review of herbal marijuana alternatives (K2, Spice), synthetic cathinones (bath salts), kratom, Salvia divinorum, methoxetamine, and piperazines (2012) J Med Toxicol, 8 (1), pp. 15-32

← 1 2 3 →